Prostate Cancer News on BioPortfolio

Manufacturing line set up for novel prostate cancer product

Recipharm the contract development and manufacturing organisation CDMO and LIDDS have collaborated to set up a manufacturing line for LIDDS novel prostate cancer drug Liproca Depot at Recipharms development facility in Solna Sweden.

Abiraterone for metastatic hormone sensitive prostate cancer

Prof Petrylak talks with ecancer at the Best of ASCO 2017 meeting in Miami about the early use of the CYP17A1 inhibitor abiraterone for patients with metastatic hormone sensitive prostate cancer.He goes on to discuss the data from and the...

Changing the standard of care Metastatic prostate cancer

Dr Domingo speaks with ecancer at the Best of ASCO meeting in Miami to discussÂMemorial Cancer Institute's approach to treating prostate cancer.She discusses the recent findings that are changing standard of care with metastatic prostate cancer that...

Recipharm and LIDDS establish industrial manufacturing capabilities

Recipharm and LIDDS have together set up a manufacturing line for LIDDS novel prostate cancer drug LiprocaÂDepot at Recipharm in Solna Sweden.The manufacturing line is dedicated to the first product based on LIDDS innovative NanoZolidÂtechnology. Clinical ...

Pages